$MTH

Meritage Homes (NYSE:MTH) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings

Meritage Homes (NYSE:MTH) reported Q2 2026 results with revenue down 14.3% year on year to $1.40 billion, below analyst expectations, according to the company and the article. Non-GAAP adjusted EPS was $1.42, up 9.2% versus consensus. The firm cited softer spring demand amid macro uncertainty and volatile interest rates.

Original reporting
Published Jul 29, 2026, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 10:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Meritage Homes (NYSE:MTH) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings — source image
Decision brief

The 30-second read

$MTHBearishMed
01

Why it matters

Traders can reassess near-term revenue trajectory versus profitability resilience, using the stated revenue miss, adjusted EPS beat, and backlog growth as the key cross-checks.

02

Market read

Q2 shows weaker top-line demand but better-than-expected adjusted EPS, with backlog growth suggesting some demand is being pulled forward into future deliveries.

03

What to watch

The article highlights backlog growth and community close-out acceleration, but does not quantify cancellations, pricing, or gross margin drivers that could clarify whether the revenue miss is temporary.

Relevance 6/10Novelty 6/10Timing: after-hours/late-day reaction to Q2 CY2026 results

Background

Meritage Homes is a US single-family homebuilder; the article frames Q2 results against a softer spring selling season and volatile interest rates.

Company-level read

Ticker impact

$MTHBearishMedium confidence
Context

Meritage Homes reported Q2 CY2026 revenue of $1.40B, down 14.3% YoY, missing analyst revenue expectations while adjusted EPS beat by 9.2%.

Expected impact

Near-term downside bias or choppy trading until revenue/backlog trends stabilize; EPS beat may limit downside.

Evidence & confidence

Article cites a revenue decline and macro/interest-rate pressure on buyer psychology, while EPS beat appears driven by profitability rather than top-line strength.

Market effects

Reinforces homebuilder cyclicality and rate sensitivity, with margin pressure and weaker absorptions consistent with a softer demand backdrop.

Mentions pockets of solid performance and accelerated close-outs in some markets, implying dispersion across builder footprints.

Limited direct global linkage; primarily US housing demand and interest-rate transmission.

Counterpoint

Backlog growth (to $661.9M) and EPS beat suggest demand may be deferred rather than broken, supporting a rebound if rates stabilize.

Key entities

  • Meritage Homes

    Homebuilder reporting Q2 CY2026 revenue decline and adjusted EPS beat, with commentary attributing softness to macro uncertainty and volatile interest rates.

Related articles

$MTHMed

Meritage Homes CORP (MTH): Results of Operations and Financial Condition

Meritage Homes CORP (MTH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 mth20260630earningsrelease.htm EX-99.1 Document Exhibit 99.1 Contacts: Emily Tadano, VP Investor Relations and External Communications (480) 515-8979 (office) investors@meritagehomes.com Meritage Homes reports second quarter 2026 results SCOTTSDALE, Ariz., July 29, 2026

$KRPMed

Kimbell Royalty Q2 Earnings Call Highlights

Kimbell Royalty (NYSE:KRP) reported record Q2 adjusted EBITDA of $84.9 million, with cash G&A of $5.9 million ($2.50 per BOE). It declared a $0.47 per common unit cash distribution, up 15% QoQ, and said 47% may be return of capital. The borrowing base rose to $660 million; debt was $478.7 million. Rig activity and production varied by basin.

$KMPRMed

Kemper Q2 Earnings Call Highlights

Kemper (NYSE:KMPR) reported Q2 results and discussed credit-loss allowances tied to surplus notes in its reciprocal exchange, including a $21 million pre-tax charge on $36 million of notes. Holding-company liquidity was $766 million and debt-to-capital rose to 28.3%. Personal auto normalized combined ratio was 102% and commercial 93.7%, with California rate actions and restructuring savings over $80 million run-rate.

$KOPMed

Koppers Q2 Earnings Call Highlights

Koppers (NYSE:KOP) reported Q2 updates on capital spending of about $24M, shareholder returns of $47M, and debt reduction of $22M in the first half. Liquidity was $390M with net debt of $857M and net leverage at 3.5x. The board raised its dividend to $0.09/share. KOP kept 2026 sales guidance at $1.9B-$2.0B but cut adjusted EBITDA to $240M-$250M and EPS to $3.80-$4.20.

$KNTKMed

Kinetik Q2 Earnings Call Highlights

Kinetik (NYSE:KNTK) Q2 earnings call said Waha pricing normalization and faster curtailment return, higher WTI and liquids assumptions, and system operating improvements supported a revised outlook. It raised 2026 capex to about $560M, expects Q3 Adjusted EBITDA $260M-$270M and Q4 $270M-$280M, and lifted 2026 volume growth to mid- to high-single digits.

$KRMNMed

Karman Q2 Earnings Call Highlights

Karman (NYSE:KRMN) reaffirmed full-year organic growth of 25% or more after Q2 organic revenue rose 24.4% YoY. Management expects second-half revenue to rise sequentially, with Tactical Missiles and IDS, Hypersonics, and Space and Launch as key drivers. Karman converted one contingent supply agreement into a firm contract and plans capacity expansion, plus a £70m ($94m) Walker Precision acquisition.